Tech Company Financing Transactions

VenatoRx Pharmaceuticals Funding Round

VenatoRx Pharmaceuticals closed a $42 million Series B funding round on 7/26/2017. Investors included Versant Ventures, Abingworth and Foresite Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

30 Spring Mill Dr.
Malvern, PA 19355
USA

Phone

(610) 644-8935

Website

www.venatorx.com

Email Address

[email protected]

Overview

VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Christopher Burns

        

Chief Medical Officer

Tim Henkel

        

Chief Operating Officer

Ezra Felker

        

VP - Bus. Development

Daniel Pevear

        

VP - Bus. Development

Luigi Xerri

        

Browse more venture capital transactions:

Prev: 7/26/2017: Sotera Wireless venture capital transaction
Next: 7/26/2017: Sebacia venture capital transaction

Share this article

Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary